The above results indicated that although Rbpj induced the expression of inhibitory receptors and RIN1 was able to well simulate the role of CD8+ TRbpj-KD in vivo, RIN1 enhancement of T cells does not act directly on T cells, but probably indirectly through HCC cells. The gene discussed is CD8A; the disease is hepatocellular carcinoma.